Anti-melanoma differentiation-associated protein 5 (anti-MDA5) is seen in 10–35% of cases of dermatomyositis and it is an independent risk factor for interstitial lung disease-related mortality. This evidence concerns the gene IFIH1 and interstitial lung disease.